Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 242Neoplasms, Plasma Cell 50Lymphoma 45Lymphoma, Mantle-Cell 40Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Non-Hodgkin 30Recurrence 29Lymphoma, Follicular 24Leukemia, Myeloid, Acute 24Lymphoma, Large B-Cell, Diffuse 23Waldenstrom Macroglobulinemia 22Lymphoma, B-Cell, Marginal Zone 20Leukemia 20Immunoglobulin Light-chain Amyloidosis 18Leukemia, Lymphocytic, Chronic, B-Cell 14Myelodysplastic Syndromes 12Carcinoma, Non-Small-Cell Lung 12Neoplasms 11Hodgkin Disease 11Burkitt Lymphoma 10Breast Neoplasms 10Lymphoma, T-Cell, Peripheral 9Lymphoma, Large-Cell, Anaplastic 9Lymphoma, B-Cell 9Lung Neoplasms 9Immunoblastic Lymphadenopathy 9Hematologic Neoplasms 9Prostatic Neoplasms 8Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, T-Cell 8

Interventions

Everolimus 3liposomal doxorubicin 2Sorafenib 2Panobinostat 2Injections 2toripalimab 1titanium silicide 1temsirolimus 1satraplatin 1pembrolizumab 1netrin-1 inhibitor NP137 1navoximod 1mogamulizumab 1ixabepilone 1fludarabine 1apatinib 1Vinorelbine 1S 1 (combination) 1Radiosurgery 1Pemetrexed 1Paclitaxel 1Oxaliplatin 1Nivolumab 1Linoleic Acids, Conjugated 1Leucovorin 1Lenalidomide 1Lapatinib 1Interferon-gamma 1Immune Checkpoint Inhibitors 1Hydroxyurea 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Advanced Solid Tumors × Bortezomib × Clear all
NCT01497626 2016-02-17

Lapatinib and Bortezomib in Patients With Advanced Malignancies

Georgetown University

Phase 1 Terminated
15 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡